September 2026
The global cancer therapeutics market size was evaluated at USD 232.14 billion in 2026 and is expected to surpass around USD 501.07 billion by 2035 with a CAGR of 8.95%.
September 2026
The cancer therapeutics and biotherapeutics market size reached USD 228.73 billion in 2026, with leading cancer therapeutics and biotherapeutics market companies including Amgen Inc., Bristol-Myers Squibb, Celgene Corporation.
September 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 2.14 billion in 2026 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
September 2026
The global colorectal cancer therapeutics market size is expected to hit around USD 19.95 billion by 2034 from USD 12.79 billion in 2024 with a CAGR of 4.55%.
September 2026
The global breast cancer therapeutics market size was valued at USD 35.91 billion in 2026 and is expected to hit around USD 66.72 billion by 2035, at a CAGR of 7.27%.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
July 2026
The global next-generation cancer therapeutics market size was evaluated at USD 99.34 billion in 2026 and is predicted to hit around USD 186.65 billion by 2035, growing at a CAGR of 7.27%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
February 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.21 billion in 2025 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
January 2026
The global peptide-based cancer therapeutics market size was evaluated at USD 9.47 billion in 2025 and is predicted to hit around USD 24.85 billion by 2035, growing at a CAGR of 10.13%.
December 2025
The global small cell lung cancer therapeutics market size is projected to hit around USD 22.86 billion by 2035 from USD 7.25 billion in 2025 with a CAGR of 12.17%.
July 2025
The pet cancer therapeutics market size was estimated at USD 448.03 million in 2023 and is projected to surpass around USD 1,150.70 million by 2034 with a CAGR of 9.89%.
September 2026
The homecare diagnostics & therapeutics market size accounted for USD 291.51 billion in 2026 and is expected to hit USD 577.56 billion by 2035, with a CAGR of 7.90%.
September 2026
The global cancer registry software market size is expected to increase from USD 106.52 million in 2026 to hit around USD 301.40 million by 2035, with a CAGR of 12.28%.
September 2026
The global cancer biomarkers market size was estimated at USD 17.49 billion in 2026 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
September 2026
The pruritus therapeutics market size stood at USD 12.26 billion in 2026, with major pruritus therapeutics market companies including Bristol-Myers Squibb, Novartis AGÂ , Pfizer Inc.,Teva Pharmaceuticals.
September 2026
The global next-generation cancer diagnostics market size is projected to hit around USD 46.43 billion by 2035 from USD 20.28 billion in 2026, with a CAGR of 9.25%.
September 2026
The infectious disease therapeutics market size is calculated at USD 37.67 billion in 2026 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
September 2026
The mRNA therapeutics market size was valued at USD 22.30 billion in 2026 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
September 2026
The global cancer vaccine market size was calculated at USD 11.32 billion in 2024 and is projected to hit around USD 33.38 billion by 2034 with a soild CAGR of 11.42%.
September 2026
The global stomach cancer treatment market size is estimated to surpass around USD 19.42 billion by 2035 from USD 6.84 billion in 2026, with a solid CAGR of 12.31%.
September 2026
The global head and neck cancer drugs market size surpassed USD 20.09 billion in 2026 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
September 2026
The cancer biopsy market size is estimated at USD 43.42 billion in 2026 and is expected to hit around USD 196.68 billion by 2035, growing at a CAGR of 18.33%.
September 2026
The global oral cancer rapid test kit market size is estimated to hit around USD 3.94 billion by 2035 increasing from USD 2.50 billion in 2026, with a CAGR of 5.17%.
September 2026
The global scleroderma therapeutics market size is projected to surpass around USD 4.48 billion by 2035 increasing from USD 2.88 billion in 2026, with a CAGR of 5.04%.
September 2026
The global small interfering RNA (siRNA) therapeutics market size is estimated to hit around USD 528.78 billion by 2035 increasing from USD 214.41 billion in 2026, with a CAGR of 10.55%.
September 2026
The global lung cancer surgery market size was evaluated at USD 1.64 billion in 2026 and is predicted to hit around USD 2.76 billion by 2035, growing at a CAGR of 5.95%.
September 2026
The global metastatic non-small cell lung cancer market size was evaluated at USD 20.45 billion in 2026 and is predicted to hit around USD 50.30 billion by 2035, growing at a CAGR of 10.52%.
September 2026
The global melanoma therapeutics market size accounted for USD 8.16 billion in 2026 and is expected to hit around USD 19.61 billion by 2035, at a CAGR of 10.25%.
September 2026
The global targeted therapeutics market size was estimated at USD 91.76 billion in 2026 and is projected to hit around USD 163.91 billion by 2035 with a CAGR of 6.69%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com